Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors
Clinical trial NCT05539157 · UNKNOWN
Trial details
- NCT number
- NCT05539157
- Sponsor
- Immorna Biotherapeutics, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-18
- Primary completion
- 2024-03-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.